Trademark Overview
On Tuesday, July 1, 2025, a trademark application was filed for ACCUMULUS TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ACCUMULUS TECHNOLOGIES trademark a serial number of 99261835. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, November 21, 2025. This trademark is owned by Accumulus Synergy, Inc.. The ACCUMULUS TECHNOLOGIES trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Software as a service (SAAS) services featuring software for aggregating, converting, processing and transferring health, medical and scientific data to a cloud platform enabling the exchange of data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations and global health regulators, and other government agencies for the purpose of expediting regulatory review of pharmaceutical products
Downloadable electronic publications in the nature of articles in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem
Arranging and conducting of symposia in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem; Education services, namely, providing seminars and non-downloadable webinars in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem
Promoting the interests of people concerned with modernizing and streamlining regulatory interactions across the life sciences ecosystem issues; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem; Promoting public awareness of the need for modernizing and streamlining regulatory interactions across the life sciences ecosystem by means of public advocacy